The main inspiration for creation of this work was from the book by Gabrielsson and Weiner\[[@ref1]\]. Authors of chapter "PK 2 - One compartment oral data" (pages 333-340) aimed at the modeling of oral administered substance A using one compartment model presented first order input model known as Bateman function with a lag time\[[@ref2][@ref3][@ref4][@ref5][@ref6]\]. Parameter estimation by WinNonlin version 1.1 (Scientific Consulting Inc., Apex, NC) were performed.

Bateman function in [fig. 1](#F1){ref-type="fig"} presents a concave function on the interval 0-100 min, but it does not satisfactorily describe the measured points on the interval 40-100 min (dashed line in [fig. 1](#F1){ref-type="fig"}). Our working hypothesis for the explanation of the pseudolinear phenomena - plateau was that the atypical shape of the measured profile on the interval 40-100 min is caused by the gastrointestinal (GI) and the circulation system. Glucose is used as second example with the atypical shape of the measured concentration profile on the interval 15-30 min. There are also other examples of the atypical shape of the concentration-time profile of oral administered drug, such as L-arginine\[[@ref7]\], vitamin C\[[@ref8]\], ibuprofen\[[@ref9]\], fenobam\[[@ref10]\], paracetamol\[[@ref11]\] and anthocyanins\[[@ref12]\].

![Observed data and model-predicted concentration-time profile after oral administration of 100 μ g of substance A to one human volunteer.\
Circles represent measured values, full squares represent omitted measured value in 15^th^ min, solid line represents one compartment model with a time delay approximation, dotted line represents atypical, hypothetic linear shape of measured concentration-time profile of substance A on the time interval 40-100 min. Observed data adapted from J. Gabrielsson, and D. Weiner, Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Application, 2^nd^ edition, pp. 333-340, copyright 1997, with permission of Swedish Pharmaceutical Press.](IJPhS-75-171-g001){#F1}

MATERIALS AND METHODS {#sec1-1}
=====================

A human volunteer was given a single oral dose comprising 100 μg of substance A. Consequently, the frequent sampling to obtain the concentration-time data was done at 10, 15, 20, 30, 40, 60, 90, 120, 180, 210, 240, 300, and 360 min after substance A administration\[[@ref1]\]. Two other human volunteers (one male and one female) were given 75 g of anhydrous glucose\[[@ref13]\] in 250 ml water solution within 1-2 min at time zero. Approval of the study protocol was obtained from the Ethic Committee of the Institute of Experimental Endocrinology of Slovak Academy of Sciences\[[@ref13]\]. Frequent sampling oral glucose tolerance test was performed by the criteria of Expert Committee on Diagnosis and Classification of Diabetes Mellitus\[[@ref14]\]. The blood samples were collected at 15 min before the glucose was administered and at 8, 15, 22, 30, 45, 60, 90, 120, 140, 160, and 180 min after the glucose was administered. Determination of glucose plasma concentrations was carried out by using the glucose oxidize method (Boehringer Manheim, Germany)\[[@ref13]\].

Structural model construction: {#sec2-1}
------------------------------

Inclusion of the GI system to the hemodynamic circulatory model ([fig. 2](#F2){ref-type="fig"}) gives the option to analyze the plateau phenomena on the measured concentration-time profile shown in [fig. 1](#F1){ref-type="fig"}. The scheme of the proposed structural model, with the oral substance dose D as input and the substance blood concentration in the sampling subsystem C~S~ as output, includes the cardiopulmonary subsystem CP, the portal subsystem P, the liver subsystem L, the GI subsystem, the other subsystems O and the sampling subsystem S. Assuming that all of the significant subsystems shown in [fig. 2](#F2){ref-type="fig"} within the range of measured concentrations formalized behave as linear dynamic systems, then i^th^ subsystem can be described by the transfer function H~i~ presented the general mathematical model of the subsystem as well-stirred model with time delay:

![The scheme of the hemodynamic circulatory model included gastrointestinal subsystem.\
D is substance dose, CP is cardiopulmonary subsystem, GI is gastrointestinal subsystem, L is liver subsystem, *P* is portal subsystem, O is other organ subsystem, S is sampling subsystem, M is amount of the substance per unit of time, A is absorption, Q is plasmatic blood flow, C is substance blood concentration, Hv is hepatic vein, RA is right atrium, LV is left ventricle.](IJPhS-75-171-g002){#F2}

![](IJPhS-75-171-g003.jpg)

![Gastrointestinal subsystem.\
*M*~A~ is absorbed amount per unit of time, *D* is the dose, AS is absorption site, *T*~A~ is mean residence time of the absorption subsystem, GE is gastric emptying, *F* is fraction, κ is time delay.](IJPhS-75-171-g004){#F3}

RESULTS AND DISCUSSION {#sec1-2}
======================

The final outcome of the processed data obtained from the human volunteer is presented in [fig. 4](#F4){ref-type="fig"} (substance A), 5-6 (glucose) and Tables [1](#T1){ref-type="table"}-[3](#T3){ref-type="table"}.

![Concentration-time profile of substance A and influence of its absorbed fractions. Circles represent measured values, solid line C represents model approximation, C~1~ and C~2~ represent partial concentration-time profile developed by fractio n F~1~ and F~2~, respectively, peak 1 is the effect of the sum of the partial profiles C~1~ and C~2~, peak 2 is the response of the deep compartment and the circulation system effect on peak 1.](IJPhS-75-171-g005){#F4}

###### 

MODEL ESTIMATED PARAMETERS OF THE GASTROINTESTINAL SUBSYSTEM

![](IJPhS-75-171-g006)

###### 

MODEL ESTIMATED PARAMETERS OF THE CIRCULATION SUBSYSTEM
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###### 

MODEL DERIVED PARAMETERS AND COMPARED PARAMETERS BY HEMODYNAMIC CIRCULATORY MODEL AND ESTIMATED USING BATEMAN FUNCTION

![](IJPhS-75-171-g008)

Figs. [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"} show the measured and modeled concentration-time profile C of substance A and glucose 1 and the influence of the first absorbed fraction F~1~ and the second absorbed fraction *F*~2~. The absorbed fractions F~1~ and F~2~ expressed by partial concentration-time profiles *C*~1~ (dashed line) and C~2~ (dotted line), respectively, are responsible for the main peak 1 of the final concentration-time profile C and presents the result of the effect of gastric emptying. The final shape of the concentration-time profile C for t≤60 min is expressed as:

![Concentration-time profile of glucose 1 and influence of its absorbed fractions. Circles represent measured values, solid line C represents model approximation, C1 and C2 represent partial concentration-time profile developed by fracti on F~1~ and F~2~, res pectively, peak 1 is the effect of the sum of the partial profiles C~1~ and C~2~, peak 2 is the response of the deep compartment and the circulation system effect on peak 1.](IJPhS-75-171-g009){#F5}

C(t)=C~1~ (t)+C~2~ (t)

where C~1~ and C~2~ are the partial concentration-time profiles developed by fraction F~1~ and F~2~, respectively. Consequently, the secondary peak 2 is the time transformed peak 1 probably influenced by the deep compartment and the circulation system. [fig. 6](#F6){ref-type="fig"} shows the measured and modeled concentration-time profile of glucose 2. In comparison with concentration-time profile of glucose 1 and substance A, concentration-time profile glucose 2 comprises only one absorbed fraction.

![Concentration-time profile of glucose 2 and influence of its absorbed fractions. Circles represent measured values, solid line C represents model approximation, C~1~ represents partial concentration-time profile developed by fraction *F*, peak 1 is the effect of the partial profile C~1~, peak 2 is the response of the deep compartment and the circulation system effect on peak 1.](IJPhS-75-171-g010){#F6}

The model estimated parameters of the GI and the circulation subsystems are listed in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively. The model parameters of the GI subsystem include absorbed fractions F~1~ and F~2~, time delays τ~1~ and τ~2~, mean residence time of the absorption subsystem T~A~ and MRT~GI~. Obtained results of the model approximation show approximately twice more value of the second fraction contrary to the first fraction ([Table 1](#T1){ref-type="table"}).

The model parameters of the circulation subsystem include plasmatic blood flow in the CP subsystem Q~CP~, gain of the liver, portal, and the other organ subsystems as G~L~, G~P~, and G~O~, respectively, time delay of the other subsystem τ~O~, mean residence time of the liver, portal, and the other organ subsystems as T~L~, T~P~, and T~O~, respectively, and MRT~CIRC~ are listed in [Table 2](#T2){ref-type="table"}.

The comparison between derived or estimated parameters by our developed hemodynamic circulatory model and parameters estimated by using the Bateman function is listed in [Table 3](#T3){ref-type="table"}.

Our work as a reanalysis of the study of Gabrielsson and Weiner\[[@ref1]\], was focused on the identification of the system defined by the oral administered substance A and frequent sampling oral glucose tolerance test data as the input and the measured concentration-time profile as the output by hemodynamic circulatory structural model included GI subsystem. This is for the substances with high coefficient of absorption.

While one compartment open model (Bateman function) was not capable of fitting the measured data within the time interval 40-100 min [fig. 1](#F1){ref-type="fig"} in case of substance A and the time interval 15-30 min in case of glucose, our model approximation presents a good fitting of the measured values within this interval (figs. [4](#F4){ref-type="fig"}-[6](#F6){ref-type="fig"}). The shape of final concentration-time profile C as the result of the parameters estimation by our structural model is characterized by the individual peaks 1 and 2. Regarding obtained results of our modeling, the peak 1 is expressed by the sum of the partial concentration-time profiles C~1~ and C~2~ related to the individual absorbed fractions F~1~ and F~2~, respectively, which suggest the effect of the GI system. The second peak 2 presents the influence mainly of the circulation system included the deep compartment to the final concentration-time profile of substance A in the observed human subject. In [Table 1](#T1){ref-type="table"}, the first fraction F~1~ (34.425% - substance A) and (33% - glucose 1) was absorbed in the small intestine with the time delay of 11.579 min (substance A) and 1.731 min (glucose 1) compared to the second absorbed fraction F~2~ (65.575% - substance A) and (66% - glucose 1) with the time delay of 27.262 min (substance A) and 13.398 min (glucose 1). Glucose 2 had only one fraction with time delay of 7.751 min.
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[Table 3](#T3){ref-type="table"} shows to the comparison between the individual absorption k~a~ and elimination k~el~ rate constants. Absorption rate constant k~a~\* according to study\[[@ref1]\] of 0.043 l/min appears 2 times higher values in comparison with our estimated value k~a~ of 0.022 l/min. The elimination rate constant k~el~\* (0.009 l/min) according to study\[[@ref1]\] presents similar values compared to calculations (Eq. 2) related to our developed structural model (0.008 l/min and 0.295 l/min, respectively). The value of mean residence time MRT~W~ of the whole body calculated by our structural model was 130.646 min (substance A), 38.756 min (glucose 1) and 43.067 (glucose 2). Model estimated value of k~a~ for glucose 1 is 0.35, which is similar to the value estimated by Bateman function (0.47) and for glucose 2 is 0.922 is 3 times higher as compared to the value estimated by using Bateman function (0.365). Model estimated values k~e~ for glucose 1 and 2 are 0.41 and 0.39, respectively and they are very similar to the values estimated by using Bateman function ([Table 2](#T2){ref-type="table"}).

In summary, obtained model results show a good approximation of the final concentration-time profile of substance A and glucose by our hemodynamic circulatory structural model compared to the Bateman function. Our work presents the validation of the hypothesis that the atypical shape of measured concentration-time profile of oral administered substance A and glucose single dose was due to the effect of the GI subsystem and the circulation system included the deep compartment.\[[@ref18]\]
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